KARYOPHARM THERAPEUTICS INC earnings per share and revenue

25K earnings per share for the last quarter are -0.23 EUR whereas the estimation was -0.25 EUR which accounts for 8.20% surprise. Company revenue for the same period amounts to 29.50 M EUR despite the estimated figure of 34.46 M EUR. Estimated earnings per share for the next quarter are -0.26 EUR, and revenue is expected to reach 33.16 M EUR. Also watch annual changes over time to get a bigger picture of 25K earnings per share and revenue dynamics.